Why Join the ‘Microbiome Movement’?
Using insight gained from the most successful microbiome organizations across the globe, the only end to end drug development meeting is back to help accelerate emerging and well established companies discover, develop and deliver a new generation of microbiome-based therapeutics.
What’s New for 2017?
A dedicated forum in tackling the challenges of developing a microbiome-based therapeutic, Microbiome Drug Development Summit will use industry case studies to develop your knowledge around four core areas of therapeutic advancement :
We have also introduced NEW 15 minute sessions for more focused discussions around the principles of developing therapeutics.
"This will be the event for leading drug developers to learn from the latest case studies" - Rodolphe Clerval, CBO, Enterome